Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for cevostamab in relapsed/refractory multiple myeloma, a Phase 1/2 study in patients with prior BCMA exposure, currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cevostamab (cevostamab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING